BACKGROUND: Neointima formation is a characteristic feature of atherosclerosis and post-angioplasty restenosis, in which various soluble factors and mechanical injury stimulate signalling pathways in vascular smooth muscle cells (VSMC), promoting their migration and proliferation, and the eventual formation of the neointima. The transcription factor NF-kappaB has been shown to play a pivotal role in this process. Hexamethylene bisacetamide, an inhibitor of VSMC proliferation, induces the mRNA expression of HEXIM1 (hexamethylene bisacetamide-inducible protein 1). However, the protein expression and function of HEXIM1 remain unknown. RESULTS: In the present study, we demonstrated that HEXIM1 localizes in the cytoplasm and nucleus, and its nuclear expression is restricted to discrete speckled areas. Treatment of VSMC with hexamethylene bisacetamide up-regulated HEXIM1 expression, not only in mRNA but also protein levels. Moreover, HEXIM1 is shown to suppress the transcriptional activity of NF-kappaB via its C-terminal leucine-rich domain. A glutathione-S-transferase pull down assay indicated that HEXIM1 interacts with the p65 subunit of NF-kappaB. In VSMC, treatment with hexamethylene bisacetamide resulted in a down-modulation of the transcription of NF-kappaB target genes. CONCLUSION: We may therefore conclude that HEXIM1 plays an inhibitory role in NF-kappaB-dependent gene expression in VSMC and is the candidate of a novel therapeutic target for inhibition of VSMC proliferation.

This article has been cited by other articles:

				A. Asakura Vascular Endothelial Growth Factor Gene Regulation by HEXIM1 in Heart Circ. Res., February 29, 2008; 102(4): 398 - 400. [Full Text] [PDF]

				I. Oven, N. Brdickova, J. Kohoutek, T. Vaupotic, M. Narat, and B. M. Peterlin AIRE Recruits P-TEFb for Transcriptional Elongation of Target Genes in Medullary Thymic Epithelial Cells Mol. Cell. Biol., December 15, 2007; 27(24): 8815 - 8823. [Abstract] [Full Text] [PDF]

				S. A. Dames, A. Schonichen, A. Schulte, M. Barboric, B. M. Peterlin, S. Grzesiek, and M. Geyer Structure of the Cyclin T binding domain of Hexim1 and molecular basis for its recognition of P-TEFb PNAS, September 4, 2007; 104(36): 14312 - 14317. [Abstract] [Full Text] [PDF]

				M. Barboric, J. H. N. Yik, N. Czudnochowski, Z. Yang, R. Chen, X. Contreras, M. Geyer, B. Matija Peterlin, and Q. Zhou Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription Nucleic Acids Res., March 19, 2007; 35(6): 2003 - 2012. [Abstract] [Full Text] [PDF]

				J. Kohoutek, D. Blazek, and B. M. Peterlin Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters PNAS, November 14, 2006; 103(46): 17349 - 17354. [Abstract] [Full Text] [PDF]

				Q. Zhou and J. H. N. Yik The Yin and Yang of P-TEFb Regulation: Implications for Human Immunodeficiency Virus Gene Expression and Global Control of Cell Growth and Differentiation Microbiol. Mol. Biol. Rev., September 1, 2006; 70(3): 646 - 659. [Abstract] [Full Text] [PDF]

				W.-J. HE, R. CHEN, Z. YANG, and Q. ZHOU Regulation of Two Key Nuclear Enzymatic Activities by the 7SK Small Nuclear RNA Cold Spring Harb Symp Quant Biol, January 1, 2006; 71(0): 301 - 311. [Abstract] [PDF]

				D. Blazek, M. Barboric, J. Kohoutek, I. Oven, and B. M. Peterlin Oligomerization of HEXIM1 via 7SK snRNA and coiled-coil region directs the inhibition of P-TEFb Nucleic Acids Res., December 23, 2005; 33(22): 7000 - 7010. [Abstract] [Full Text] [PDF]

				H. Jiang, F. Zhang, T. Kurosu, and B. M. Peterlin Runx1 Binds Positive Transcription Elongation Factor b and Represses Transcriptional Elongation by RNA Polymerase II: Possible Mechanism of CD4 Silencing Mol. Cell. Biol., December 15, 2005; 25(24): 10675 - 10683. [Abstract] [Full Text] [PDF]

				C. Dulac, A. A. Michels, A. Fraldi, F. Bonnet, V. T. Nguyen, G. Napolitano, L. Lania, and O. Bensaude Transcription-dependent Association of Multiple Positive Transcription Elongation Factor Units to a HEXIM Multimer J. Biol. Chem., August 26, 2005; 280(34): 30619 - 30629. [Abstract] [Full Text] [PDF]

				A. Schulte, N. Czudnochowski, M. Barboric, A. Schonichen, D. Blazek, B. M. Peterlin, and M. Geyer Identification of a Cyclin T-Binding Domain in Hexim1 and Biochemical Analysis of Its Binding Competition with HIV-1 Tat J. Biol. Chem., July 1, 2005; 280(26): 24968 - 24977. [Abstract] [Full Text] [PDF]

				N. Shimizu, R. Ouchida, N. Yoshikawa, T. Hisada, H. Watanabe, K. Okamoto, M. Kusuhara, H. Handa, C. Morimoto, and H. Tanaka HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b PNAS, June 14, 2005; 102(24): 8555 - 8560. [Abstract] [Full Text] [PDF]

				S. A. Byers, J. P. Price, J. J. Cooper, Q. Li, and D. H. Price HEXIM2, a HEXIM1-related Protein, Regulates Positive Transcription Elongation Factor b through Association with 7SK J. Biol. Chem., April 22, 2005; 280(16): 16360 - 16367. [Abstract] [Full Text] [PDF]

				J. H. N. Yik, R. Chen, A. C. Pezda, and Q. Zhou Compensatory Contributions of HEXIM1 and HEXIM2 in Maintaining the Balance of Active and Inactive Positive Transcription Elongation Factor b Complexes for Control of Transcription J. Biol. Chem., April 22, 2005; 280(16): 16368 - 16376. [Abstract] [Full Text] [PDF]

				J. H. N. Yik, R. Chen, A. C. Pezda, C. S. Samford, and Q. Zhou A Human Immunodeficiency Virus Type 1 Tat-Like Arginine-Rich RNA-Binding Domain Is Essential for HEXIM1 To Inhibit RNA Polymerase II Transcription through 7SK snRNA-Mediated Inactivation of P-TEFb Mol. Cell. Biol., June 15, 2004; 24(12): 5094 - 5105. [Abstract] [Full Text] [PDF]

				R. Chen, Z. Yang, and Q. Zhou Phosphorylated Positive Transcription Elongation Factor b (P-TEFb) Is Tagged for Inhibition through Association with 7SK snRNA J. Biol. Chem., February 6, 2004; 279(6): 4153 - 4160. [Abstract] [Full Text] [PDF]